Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

High Cholesterol: later-stage trial registry

2 of 5 indexed High Cholesterol trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

High Cholesterol: 5 US clinical trials tracked, 2 recruiting.

High Cholesterol is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Daxor Corporation, running 1 of these trials.

Enrollment posture brief

Registry condition high-cholesterol

OPEN 2 | RECR 40% | LATE 1 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%High Cholesterol (this)40%
Open-enrollment share among volume-matched conditions near High Cholesterol

High Cholesterol lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for High Cholesterol on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. High Cholesterol is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates High Cholesterol research.

    Daxor Corporation accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical High Cholesterol enrolment sits around 120 participants.

    Median target enrolment is 120 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. High Cholesterol research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on High Cholesterol records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Poor colon cancer screening video Behavioral
1 trials
Good colon cancer screening video Behavioral
1 trials
Poor high cholesterol video Behavioral
1 trials
Good high cholesterol video Behavioral
1 trials
5 mg rosuvastatin calcium with a Web App (combination product) Combination
1 trials
BVA-200 Diagnostic test
1 trials
Physical Activity Comparator Behavioral
1 trials
Nutrition Education and Food Delivery Behavioral
1 trials

US sites by state

Facility locations filed on High Cholesterol trials. A trial with sites in several states counts in each.

Tennessee 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Indiana 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this High Cholesterol page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This High Cholesterol condition card totals 5 registered trials; most-linked intervention Poor colon cancer screening video; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.